Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy
In this systematic review, originally published in the journal Future Oncology, researchers describe the quality of the reporting of adverse events in publications of pivotal clinical trials testing new drugs in solid tumors.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>